摘要
目的分析宜昌市2010—2015年耐多药肺结核患者发现治疗情况,为下一步制定耐药肺结核防治策略提供依据。方法收集2010—2015年耐多药肺结核患者的相关资料,进行统计分析。结果 2010—2015年宜昌市共发现MDR-TB 218例,其中男性160例,占73.4%;女性58例,占26.6%;男女性别比为2.8∶1。职业以农民为主,占55.0%(120/218)。发现的耐多药肺结核患者中,纳入治疗153例(70.2%),各年间纳入治疗率有统计学差异(P<0.05)。6月末痰涂片阴转率为70.6%,6月末痰培养阴转率为50.3%,各年间6月末痰涂片阴转率有统计学差异(P<0.05),但6月末培养阴转率无统计学差异。完成疗程76例,治愈36例,治愈率47.4%。结论宜昌市通过实施国际项目在耐药结核病患者发现、诊疗和督导管理方面取得了很大成绩,但在病人纳入治疗和治疗效果方面仍需进一步完善。
Objective To analyze the status of finding and treatment of multidrug-resistant tuberculosis（MDR-TB）patients in Yichang City from 2010 to 2015,so as to provide the evidence for further developing the control strategy of MDR-TB. Methods The data of MDR-TB patients in Yichang from 2010 to 2015 were collected and analyzed statistically.Results A total of 218 MDR-TB cases were detected in Yichang City from 2010 to 2015,in which 160 patients were male,and 58 were female,and the ratio of male to female was 2.8∶1. Most of the cases were farmers（55.0%,120/218）. However,only153 cases（70.2%） were treated in the designated hospital. The sputum smear and culture negative conversion rates within 6months were 70.6% and 50.3% respectively. The cure rate in 76 cases of treatment completion was 47.4%（36/76）.Conclusion Great achievements are made in the finding,treatment and management of MDR-TB patients in Yichang Cityfrom 2010 to 2015,but the treatment enrollment and treatment success of MDR-TB patients are still needed to be improved.
出处
《中国热带医学》
CAS
2017年第3期257-259,共3页
China Tropical Medicine
基金
中国国家卫生和计划生育委员会-比尔及梅琳达.盖茨基金会结核病防治合作项目(No.51914)
关键词
肺结核
耐多药
治疗
tuberculosis
multidrug-resistant
treatment
